Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of Merck & Co. (MSD). FDA records under its name, each linked to the record. See the Merck & Co. (MSD) group view.
As of Nov 15, 2026, FDA's public records list Schering-Plough Products with 1 drug recall. The most recent is a drug recall dated Dec 12, 2012: Temodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per package, For Oral Admi….
| Date | Record | Source |
|---|---|---|
| Dec 12, 2012 | Temodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per package, For Oral Administration, Rx Only, Cytotoxic, NDC: 0085-1519-02, SClass II · Failed Impurities/Degradation Specifications: The recall is being initiated due to an out-of-specification result in the | Drug recalls |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
